GROWTH STOCK ANALYZER Open the app
Growth Stock Analyzer › CRON growth analysis
Growth stock analysis · updated 2026-07-27

Cronos Group Inc. Common Share (CRON) growth stock analysis

Is Cronos Group Inc. Common Share a growth stock? A data-driven read on its earnings momentum, price leadership, and demand, scored against every US stock from SEC filings and daily prices, and re-ranked after every close.

Not right now by CANSLIM
19
Growth score
67
RS rating
#3,348
Rank
0/6
Traits passed
19/99
Growth score · 3348th of 4,897 US stocks
CANSLI
Six growth traits, scored 1–99

What the data says about CRON

As of the 2026-07-27 close, CRON scores 19 out of 99 on our growth-stock rating, a weak growth-stock profile. That ranks it 3348th of 4,897 rated US stocks, the top 68% of the market.

Its strongest trait is L (leader or laggard) at 52, and its weakest is A (annual earnings growth) at 8. CRON clears 0 of the six core growth traits we score per stock; the seventh, overall market direction, is judged market-wide.

On price, CRON carries a middling Relative Strength rating of 67, meaning it has outperformed about 67% of the market over the past year.

Underneath the score: quarterly earnings up 100% year over year, sales up 40%, trading 13% below its 52-week high.

CRON growth-trait breakdown

The six traits that separate real growth stocks from the rest: earnings, price leadership, and demand. Each is scored 1–99 against the whole US market. We compute them with the CANSLIM method, double-weighting earnings and relative strength.

C
Current quarterly earnings
most recent EPS growth vs. a year ago
50
A
Annual earnings growth
multi-year earnings trend
8
N
New highs & catalysts
proximity to new 52-week highs
16
S
Supply & demand
volume behind the move vs. share supply
29
L
Leader or laggard
Relative Strength within its group
52
I
Institutional sponsorship
fund accumulation and 13F ownership
30

Is CRON a growth stock?

Not right now by CANSLIM

On today’s data CRON does not clear the growth-stock bar CANSLIM sets. Scores are re-computed after every close, so this can change.

🔒 Stronger growth stocks than CRON

The stocks ranking above CRON today, the growth leaders you’d weigh against it.

See today’s top ranks for free →

🔒 CRON price history & buy range

Where CRON sits in its base, its 52-week path, and the trait trend over the past year.

Open the full CRON profile →

See where CRON ranks among every US growth stock

Every US stock scored on the traits that define a growth stock and re-ranked after each close, with the top ranks, the full trait breakdown, and today’s market read.

Open the app, free through September 1

CRON as a growth stock, frequently asked

Is CRON a good growth stock?

Not right now by CANSLIM. On today’s data CRON does not clear the growth-stock bar CANSLIM sets. Scores are re-computed after every close, so this can change.

What is CRON's growth score?

Cronos Group Inc. Common Share (CRON) scores 19 out of 99 on our growth-stock rating as of the 2026-07-27 close, ranking 3348th of 4,897 rated US stocks.

Does CRON have strong earnings growth?

CRON's most recent quarterly earnings were up about 100% year over year, with sales up 40%.

How strong is CRON's price performance?

CRON has a Relative Strength rating of 67, meaning it has outperformed roughly 67% of the US market over the trailing year.

Where can I see CRON's full analysis?

Create a free Growth Stock Analyzer account to see where CRON ranks against every US stock, the stronger growth stocks to weigh against it, and its full price and earnings history.

Want the method behind the score? Read how we grade growth stocks with CANSLIM.

More growth stocks in Medicinal Chemicals & Botanical Products